ArticleOpen forum infectious diseases2021

Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study.

Janak Koirala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.